Molgramostim biosimilar - Amoytop BiotechAlternative Names: rHuGM-CSF - Xiamen Amoytop Biotech; Topleucon
Latest Information Update: 04 Feb 2014
At a glance
- Originator Xiamen Amoytop Biotech
- Class Chemoprotectants; Granulocyte-macrophage colony-stimulating factors; Recombinant proteins
- Mechanism of Action Granulocyte colony stimulating factor receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Agranulocytosis